Milada Cvancarova

Summary

Affiliation: Cancer Registry of Norway
Country: Norway

Publications

  1. ncbi Proportion cured models applied to 23 cancer sites in Norway
    Milada Cvancarova
    Department of Registration, Cancer Registry of Norway, Institute of Population Based Cancer Research, Oslo, Norway National Resource Center for Late Effects, Department of Oncology, Oslo University Hospital, Norway
    Int J Cancer 132:1700-10. 2013
  2. ncbi Pregnancy after adolescent and adult cancer: a population-based matched cohort study
    Hanne Stensheim
    Department of Clinical and Registry based Research, Cancer Registry of Norway, Institute of Population Based Cancer Research, Oslo, Norway
    Int J Cancer 129:1225-36. 2011
  3. ncbi Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study
    Marte Lie Høivik
    Division of Medicine, Department of Gastroenterology, Oslo University Hospital, Aker, P O Box 4959 Nydalen, 0424 Oslo, Norway
    Gut 62:368-75. 2013
  4. ncbi Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones
    Andreas Stensvold
    Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway
    Prostate 72:668-76. 2012
  5. ncbi Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases
    David Scheie
    Department of Pathology, Oslo University Hospital, Rikshospitalet, P O Box 4950 Nydalen, 0424 Oslo, Norway
    Neuro Oncol 13:1225-33. 2011
  6. ncbi Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer
    Mette Sprauten
    Norwegian Radium Hospital Oslo University Hospital, Oslo, Norway
    J Clin Oncol 30:300-7. 2012

Collaborators

Detail Information

Publications6

  1. ncbi Proportion cured models applied to 23 cancer sites in Norway
    Milada Cvancarova
    Department of Registration, Cancer Registry of Norway, Institute of Population Based Cancer Research, Oslo, Norway National Resource Center for Late Effects, Department of Oncology, Oslo University Hospital, Norway
    Int J Cancer 132:1700-10. 2013
    ..The absolute estimates of the cure proportion are speculative and should not be calculated where cure is not medically anticipated...
  2. ncbi Pregnancy after adolescent and adult cancer: a population-based matched cohort study
    Hanne Stensheim
    Department of Clinical and Registry based Research, Cancer Registry of Norway, Institute of Population Based Cancer Research, Oslo, Norway
    Int J Cancer 129:1225-36. 2011
    ..9 (95% CI 0.7-1.0)]. In summary, fertility-preserving attempts have succeeded in patients with ovarian or testicular cancer and in males with Hodgkin lymphoma. Male survivors initiated pregnancies in a higher degree than female survivors...
  3. ncbi Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN Study
    Marte Lie Høivik
    Division of Medicine, Department of Gastroenterology, Oslo University Hospital, Aker, P O Box 4959 Nydalen, 0424 Oslo, Norway
    Gut 62:368-75. 2013
    ....
  4. ncbi Methods for prospective studies of adverse effects as applied to prostate cancer patients treated with surgery or radiotherapy without hormones
    Andreas Stensvold
    Department of Oncology, Oslo University Hospital, Radiumhospitalet, Oslo, Norway
    Prostate 72:668-76. 2012
    ..We compared these methods to examine changes of sexual, urinary, and bowel functions after robot-assisted prostatectomy (RALP) and conformal external beam radiotherapy (EBRT) in patients without androgen deprivation therapy (ADT)...
  5. ncbi Prognostic variables in oligodendroglial tumors: a single-institution study of 95 cases
    David Scheie
    Department of Pathology, Oslo University Hospital, Rikshospitalet, P O Box 4950 Nydalen, 0424 Oslo, Norway
    Neuro Oncol 13:1225-33. 2011
    ..The study suggests that solitary 19q loss is a negative prognostic variable and that 1p/19q loss is associated with prolonged survival also in oligodendroglial tumors without classic histology...
  6. ncbi Impact of long-term serum platinum concentrations on neuro- and ototoxicity in Cisplatin-treated survivors of testicular cancer
    Mette Sprauten
    Norwegian Radium Hospital Oslo University Hospital, Oslo, Norway
    J Clin Oncol 30:300-7. 2012
    ..Cisplatin-induced neurotoxicity and ototoxicity (NTX) are important adverse effects after chemotherapy for testicular cancer (TC). Although serum platinum is measurable years after therapy, its impact on NTX has not been evaluated...